iShares Biotechnology ETF (IBB)

Profile

https://investor.fb.com

iShares Biotechnology ETF is an exchange-traded fund that provides diversified exposure to the U.S. biotechnology industry, tracking a modified market-cap-weighted index of publicly listed biotechnology firms. Its primary function is to pool investments in leading biotech companies, enabling investors to participate in the sector’s innovation-driven growth through a single asset. The ETF includes firms engaged in cutting-edge therapeutic research, development of treatments for major diseases, and the creation of advanced tools for biotech processes. Notable holdings span various market capitalizations and feature prominent industry leaders such as Gilead Sciences, Amgen, Regeneron Pharmaceuticals, and Vertex Pharmaceuticals. This fund employs a passive management approach, aiming to replicate its benchmark’s performance by holding constituents in similar proportions. Its structure and broad reach make it a significant instrument for those seeking sector-specific exposure to biotechnology, which is recognized for its impact on healthcare advancement and treatment innovation.